B
Company · Foodtech & Agtech
Biofactoría Naturae et Salus
Spanish biotechnology company based in Valladolid, founded in 2011 (commercial launch 2013), billed as Europe's first "biofactory" extracting natural bioactive ingredients (vitamins, minerals, bioactives) from aloe vera, fungi and other plants grown on its own 200,000 m² of greenhouse crops, for use in natural food, dietary supplements and cosmetics. It is the national market leader in aloe vera juice, sells in 15+ countries, and has been capitalized largely through public regional investment (SODICAL) rather than traditional VC rounds.
Founded
2011
Founders
1
News
0
Rounds
0
Investors
1
SectorsFoodtech & Agtech, Biotechnology, Natural Cosmetics
Start-up MapFoodtech & Agtech › Alternative protein & novel ingredients
Profile updated 31 Jul 2026
Founders
J
Juan Manuel Sanz
Founder & CEO
Global models 5
GGinkgo Bioworks
United States · www.ginkgobioworks.com ↗
Biotech platform engineering organisms to biomanufacture natural ingredients at scale, mirroring Naturae's biofactory approach to producing natural compounds via biotechnology.
$796MComparable
P
Perfect Day
United States · perfectday.com ↗
Uses precision fermentation (biotech) to produce natural, animal-free food ingredients without synthetic additives, matching Naturae's clean-label biotech-for-food model.
$770MComparable
MMotif FoodWorks
United States · www.motifingredients.com ↗
Biotech company developing natural, chemical-free food ingredients for the food industry, similar to Naturae's ingredient-extraction business line.
$345MComparable
NNuritas
Ireland · www.nuritas.com ↗
Discovers and extracts natural bioactive peptides from plants for use in supplements, functional food and cosmetics, closely mirroring Naturae's extraction of bioactives from plants/fungi.
$146.5MComparable
GGeltor
United States · www.geltor.com ↗
Biofermentation company producing natural protein ingredients (collagen, elastin) sold into both food/nutrition and cosmetics, matching Naturae's dual food-and-cosmetics ingredient model.
$137MComparable
Investors 1
Funding rounds
No announced rounds on record.
News & media
No coverage on record yet.